福安药业(300194.SZ)：盐酸曲唑酮片收到药品注册证书

Core Viewpoint - Fuan Pharmaceutical has received a drug registration certificate from the National Medical Products Administration for its product, Sertraline Hydrochloride Tablets, which is effective in treating depression, including cases with or without anxiety [1] Company Summary - Fuan Pharmaceutical's wholly-owned subsidiary, Ningbo Tianheng Pharmaceutical Co., Ltd., is responsible for the development and registration of Sertraline Hydrochloride Tablets [1] - The approval of this drug expands Fuan Pharmaceutical's product portfolio in the mental health treatment sector [1] Industry Summary - The approval of Sertraline Hydrochloride Tablets highlights the growing focus on mental health treatments within the pharmaceutical industry [1] - The drug is indicated for the treatment of depression, which is a significant area of need in healthcare, particularly for patients experiencing anxiety [1]